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Immunoglobulin E (IgE) antibodies are known for trig-
gering immediate hypersensitivity reactions such as
food anaphylaxis. In this study, we tested whether
they might additionally function to amplify nascent
antibody and T helper 2 (Th2) cell-mediated re-
sponses to ingested proteins and whether blocking
IgE would modify sensitization. By using mice
harboring a disinhibited form of the IL-4 receptor,
we developed an adjuvant-free model of peanut
allergy. Mast cells and IgE were required for induc-
tion of antibody and Th2-cell-mediated responses
to peanut ingestion and they impaired regulatory T
(Treg) cell induction. Mast-cell-targeted genetic
deletion of the FcεRI signaling kinase Syk or Syk
blockade also prevented peanut sensitization. In
mice with established allergy, Syk blockade facili-
tated desensitization and induction of Treg cells,
which suppressed allergy when transferred to naive
recipients. Our study suggests a key role for IgE in
driving Th2 cell and IgE responses while suppressing
Treg cells in food allergy.
INTRODUCTION
Food allergy has emerged as a major public health issue world-
wide (Burks et al., 2012). Sensitized individuals, who have high
titers of food-specific IgE antibodies, experience a range of
immediate hypersensitivity responses including acute-onset
itching, hives, vomiting, and diarrhea all triggeredwhen food pro-
teins recognized by FcεRI-bound IgE inducemast cell activation.
The most dramatic food hypersensitivity reaction is systemic
anaphylaxis, in which vasoactive mast cell mediators induce
plasma extravasation, shock, cardiopulmonary collapse, and
death (Finkelman, 2007; Simons, 2010). The standard of care,
namely recommendation to strictly avoid foods to which theyare allergic, paradoxically deprives patients of the chance to
naturally develop oral tolerance, as would probably occur if
they were able to continue to ingest them without experiencing
harmful effects.
Following the very successful example of subcutaneous
immunotherapy in which subjects with aeroallergen sensitivity
are desensitized by injection of protein extracts (‘‘allergy shots’’),
investigators have evaluated oral desensitization strategies for
food allergy (Nowak-We˛grzyn and Sampson, 2011; Vickery
and Burks, 2010). Although achieving substantial success,
such approaches are associated with unpredictable IgE anti-
body-mediated allergic reactions, limiting their application in
practice. Several groups have now performed oral desensitiza-
tion under cover of the monoclonal anti-IgE antibody omalizu-
mab, which effectively blocks food anaphylaxis, with the
expectation that inhibiting IgE-mediated reactions would
improve the patient experience (Nadeau et al., 2011; Schneider
et al., 2013).
A growing body of evidence indicates that IgE antibodies and
mast cells might serve not only as the effectors of immediate hy-
persensitivity in subjects with established sensitivity but also as
amplifiers during initial antigen exposure in naive subjects,
potentially providing early signals for nascent Th2 cell and anti-
body responses. IgE induces mast cell production of both Th2-
cell-inducing and DC-activating cytokines (Asai et al., 2001;
Kalesnikoff et al., 2001; Kawakami and Kitaura, 2005). We
have reported that IgE and mast cells enhance immune sensiti-
zation in contact sensitivity (Bryce et al., 2004). By using an
adjuvant-free asthma model, Nakae et al. (2007a, 2007b)
demonstrated that the induction of airway inflammation and
bronchial hyperreactivity are strongly amplified by mast cells in
the airway mucosa. Additional evidence that effector cells of
allergic responses might independently function as inducers of
immune sensitization comes from studies implicating basophils
(which, like mast cells, are FcεRI+) as early drivers of Th2 cell
expansion (Mukai et al., 2005; Sokol et al., 2009). We similarly
hypothesized that IgE antibodies and mast cells might serve
not only as the effectors of food anaphylaxis but also as
important early inducers of Th2 cell responses and suppressors
of Treg cell responses to food allergens and that they mightImmunity 41, 141–151, July 17, 2014 ª2014 Elsevier Inc. 141
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such responses.
Evaluation of this hypothesis required an animal model of food
allergy in which immune sensitization could be accomplished
directly by enteral sensitization and in the absence of the immu-
nostimulatory effects of prior systemic parenteral immunization
or ingestion of immunological adjuvants commonly used in
food allergy models. For this purpose we took advantage of
inherently atopic mice in which a mutation (F709) of the IL-4 re-
ceptor a chain (IL-4ra) ITIM results in amplified signaling upon
interaction with IL-4 or IL-13, but not constitutive activation.
These mice exhibit enhanced Th2 cell responses and IgE pro-
duction and susceptibility to anaphylaxis after ingestion of the
model antigen ovalbumin (OVA) in the absence of adjuvant
(Mathias et al., 2011). We have now adapted this model to the
clinically relevant food allergen peanut and have appliedmultiple
parallel approaches that together provide strong evidence that
IgE antibodies and mast cells enhance Th2 cell responses to in-
gested allergens. Themechanism for this Th2 cell induction is the
suppression of Foxp3+ Treg cell responses, in terms of both Treg
cell numbers and function. We show that established allergic
sensitivity can be reversed when oral immunotherapy is paired
with interventions that block IgE-mediated mast cell activation
and demonstrate that pharmacologic inhibition of Syk activity
can be used to inhibit mast cell function and achieve the same
benefit as IgE blockade. Our results establish that IgE anti-
bodies, signaling via FcεRI onmast cells, not only serve to induce
anaphylactic reactions in individuals with food allergy but also
exert critical regulatory effects on adaptive immunity to ingested
proteins in emerging food allergy. Mast cells activated by IgE
support Th2 cell responses and IgE production while suppress-
ing Treg cell induction. Moreover, food ingestion under cover of
IgE signaling blockade can lead to reversal of Th2 cell responses
and induction of Treg cells in mice with established food allergy.
These results suggest that pharmacologic IgE blockade might
be of benefit to patients with food allergy.
RESULTS
IgE Antibodies Amplify Th2 Cell Responses and
Suppress Treg Cell Induction to Ingested Peanut
Although IgE antibodies are best recognized for their unique abil-
ity to trigger immediate hypersensitivity reactions in previously
sensitized subjects, there is evidence that theymight serve an in-
dependent and important function in amplifying and skewing
developing adaptive immune responses after initial antigen
exposure (Gould and Sutton, 2008). For this study, we examined
the possibility that IgE antibodies, signaling via FcεRI on mast
cells, would support Th2 cell responses to ingested food aller-
gens while suppressing the induction of Treg cells. In order to
test this hypothesis, we developed a murine model of allergy to
peanut, a very common food allergen and one associated with
particularly severe anaphylactic reactions. We have previously
reported the construction of mice (Il4ratm3.1Tch) that harbor a
targeted insertion of a mutant form of IL-4ra in which the immu-
noreceptor tyrosine-based inhibition motif (ITIM) motif is disrup-
ted (F709 mutation). These mice have normal IL-4ra expression
and do not have baseline signaling but exhibit enhanced
signaling on ligand exposure and are highly susceptible to the in-142 Immunity 41, 141–151, July 17, 2014 ª2014 Elsevier Inc.duction of allergy to ovalbumin (OVA) in an adjuvant-free inges-
tion model (Mathias et al., 2011; Tachdjian et al., 2010). They
exhibit robust anaphylaxis after food allergen ingestion, a cardi-
nal phenotype of food allergy that has previously been difficult to
reproduce in animal models.We reasoned that thesemicewould
provide an ideal tool for analysis of IgE andmast cell roles in food
allergen sensitization to a physiologically relevant allergen,
peanut.
Mice were sensitized by weekly gavage with 23 mg commer-
cial peanut butter (5mg protein) (Figure S1 available online). After
four doses, peanut-fed mice carrying the IL-4ra F709 mutation,
but not control animals, exhibited strong peanut-specific IgE
and IgG1 responses as well as robust induction of peanut-
specific Th2 cell responses (Figures 1A–1D and S2A). Consistent
with the expected induction of oral tolerance, wild-type BALB/c
mice developed a strong peanut-specific Foxp3+ Treg cell
response (Figure 1E). Peanut-specific Treg cell induction was
markedly impaired in mice with the F709 IL-4 receptor. In this
study we measured Treg cell responses by ex vivo stimulation
for 5 days with peanut antigen followed by flow cytometric eval-
uation of Foxp3+ dividing cells (Figure 1F).
Gavage challenge of peanut-sensitizedmice with 450mg pea-
nut butter (100 mg protein) elicited anaphylaxis in the IL-4ra
mutants, measured via implanted thermal transponders, as
loss of core body temperature (Figure 1G; see Figure S1 for pro-
tocol schematic). Neither unsensitized IL-4ra mutant mice nor
peanut-fed wild-type BALB/c mice had any temperature loss
(Figure 1G and data not shown), and challenge of peanut-sensi-
tized mutant mice with irrelevant protein had no effect on tem-
perature (Figure S2B). Anaphylaxis was accompanied by
elevated serum concentrations of mouse mast cell protease-1
(MMCP-1), a marker of mucosal mast cell activation (Figure 1H).
These findings demonstrate that mice with a dysregulated F709
IL-4 receptor develop intense Th2 cell, IgE, and IgG responses to
ingested peanut along with a defective induction of Treg cells
and that this immunological profile renders them exquisitely sen-
sitive to anaphylaxis after enteral peanut challenge. It is inter-
esting to note that in addition to being susceptible to deliberate
induction of sensitization with the food allergen peanut, these
mice exhibit some spontaneous sensitization to food proteins
within their standard chow diet (Figure S2C).
In order to evaluate the contributions of IgE antibodies to pea-
nut sensitization and anaphylaxis, we crossed the IL-4ramutant
animals with IgE-deficient (Igh7/) BALB/c mice (Oettgen et al.,
1994). As expected, IgE-deficient mice were fully resistant to
peanut anaphylaxis (Figure 1G). Consistent with our hypothesis
that IgE contributes to immunological sensitization in the gut dur-
ing recurrent allergen ingestion, peanut-specific IgG1 and Th2
cell responses were dramatically reduced in peanut-sensitized
mice lacking IgE (Figures 1B–1D). Treg cell induction, which
had been markedly impaired in mice with the F709 form of
IL-4ra, was fully restored in the absence of IgE (Figures 1E and
1F). Taken together, these findings provide strong evidence
that IgE antibodies support the induction of Th2 cell and antibody
responses to ingested allergens while suppressing the induction
of Treg cells.
Our results with IgE-deficient mice suggest that the applica-
tion of IgE blockade, which has been employed in clinical
food desensitization studies to block undesired anaphylactic
Figure 1. Effects of IgE and IL4raGenotypes
on Food Allergen Sensitization in the
Absence of Adjuvant
The effects of IgE on sensitization were evaluated
with completely IgE-deficient mice (Igh-7/) both
on the allergy-prone IL-4ra F709 background
(Il4ratm3.1Tch) and on wild-type BALB/c.
(A) Peanut-specific IgE levels in sera of mice sub-
jected to enteral gavage with peanut butter (PN).
Mice (n = 5–10 per group) were gavaged with
23 mg PN once a week for 4 weeks. The horizontal
line indicates the limit of detection in this ELISA.
Presence of the activating IL-4 receptor, F709, and
IgE are indicated by plus (+) or minus ().
(B) Serum titers of peanut-specific IgG1 after
sensitization.
(C) Flow cytometric analysis of intracellular IL-4
staining in CD4+ T cells from mesenteric lymph
node (MLN) cells after PN sensitization.
(D) IL-4 levels as determined by ELISA in spleno-
cyte cultures from PN-treated mice restimulated
in vitro with PN extract for 5 days.
(E) Analysis of PN-specific Treg cells expanded
from MLN cells of PN-treated mice.
(F) Representative flow cytometry plots demon-
strate dye dilution (proliferation) among CD3ε+
CD4+ MLN cells labeled with Violet CellTrace and
cultured in vitro with PN extract for 5 days. The
summary graph shows the Foxp3 phenotype of the
divided cells, gating on CD4+ viable single cells.
(G) Temperature curves after enteral challenge
with high-dose PN. p < 0.0001 by repeated mea-
sures (RM) two-way ANOVA, Il4ratm3.1Tch versus
Il4ratm3.1Tch Igh-7/.
(H) Serum MMCP-1 levels as measured by ELISA
postchallenge. Data are represented as points for
individual mice, with mean ± SEM in overlay.
Similar data were obtained in at least three sepa-
rate experiments.
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antigens. Omalizumab, the anti-IgE used in human trials, is
‘‘nonanaphylactogenic.’’ It does not bind to FcεRI-bound IgE
and therefore does not activate mast cells. In contrast, available
anti-mouse IgE reagents all exhibit some degree of mast cell
activation. In order to use these antibodies in the peanut
model, we had to mitigate this effect. Taking advantage of a
rush desensitization protocol developed by Khodoun et al.
(2013), we treated mice with anti-IgE in a 4-day build-up prior
to the first exposure to peanut. Neutralization of IgE mimicked
genetic deletion of IgE, rendering the IL-4ra mutant mice resis-
tant to anaphylactic reactions (Figure 2A). Anti-IgE treatmentImmunity 41, 141–prior to sensitization reduced Th2 cell re-
sponses and increased peanut-specific
Treg cell frequencies (Figures 2B, 2D,
and S2D).
Anti-IgE therapy in the peanut allergy
model allowed us to also examine the
effects of IgE blockade during allergen
desensitization in animals with estab-
lished peanut sensitivity. For desensitiza-
tion, anti-IgE treatment was started aweek after the final sensitizing peanut dose was administered,
after which large doses (225 mg) of peanut were administered
daily for 3 weeks. When finally challenged with peanut, mice
that had received anti-IgE did not anaphylax, as expected given
the requirement for IgE in anaphylaxis (Figure 2A). In contrast,
mice subjected to the same peanut desensitization therapy
without anti-IgE exhibited similar anaphylactic reactions to those
seen in mice that received no therapy whatsoever. Th2 cell re-
sponses were reduced in mice treated with anti-IgE plus peanut,
and peanut-specific Treg cell frequencies markedly increased
(Figures 2C, 2D, and S2E). Control desensitization therapy with
peanut alone did not elicit significant changes in Th2 cell or151, July 17, 2014 ª2014 Elsevier Inc. 143
Figure 2. Effects of Anti-IgE on Food Allergen Sensitization
(A) Temperature curves after acute enteral challenge with PN in IL-4ra F709
mutant (Il4ratm3.1Tch) mice (n = 5) treated with PN and/or anti-IgE. Mice were
sensitized by enteral gavage with PN (23 mg) once a week for 4 weeks, fol-
lowed by desensitization with PN (225 mg) once a day for 3 weeks. Anti-IgE
(100 mg total) was injected i.p. in an incremental rush protocol prior to sensi-
tization or desensitization. Abbreviations are as follows: PN+aIgE: aIgE prior to
PN sensitization; PN, PN+aIgE: PN sensitization, aIgE prior to PN desensiti-
zation; PN, PN: PN sensitization, PN desensitization. PN versus PN+aIgE: p =
0.0011; PN versus PN, PN+aIgE: p = 0.0022; PN, PN versus PN, PN+aIgE: p =
0.0002 by RM two-way ANOVA.
(B) Flow cytometric analysis of IL-4 by intracellular staining of CD4+ T cells in
MLN (n = 4–5).
(C) IL-4 staining in CD4+ MLN cells in response to desensitization with PN ±
anti-IgE (n = 5–7).
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144 Immunity 41, 141–151, July 17, 2014 ª2014 Elsevier Inc.Treg cell responses to peanut, although there were trends for
elevation in both.
Taken together these results indicate that IgE antibodies pro-
mote immune sensitization to ingested allergens. In the food-
allergy-susceptible mice harboring a dysregulated form of
IL-4ra, the presence of IgE during recurrent enteral peanut expo-
sure promoted the induction of peanut-specific Th2 cell, IgE, and
IgG1 responses while suppressing the expansion of antiallergic
Treg cells. Moreover, IgE blockade in animals with established
allergy served to reverse sensitivity with a reduction in Th2 cell
responses and expansion of Treg cells.
Mast Cells Amplify Allergic Responses to Ingested
Peanut and Suppress Peanut-Specific Treg Cell
Induction
We hypothesized that mast cells were the likely effectors of IgE-
mediated Th2 cell induction and Treg cell suppression observed
in the peanut allergymodel. In order to test this, we bred the F709
IL-4ramutation onto the C57BL/6 genetic background and then
intercrossed these mice with KitW-sh mice. These mast-cell-defi-
cient mice exhibited a dramatic (3-log) reduction in peanut-spe-
cific IgE along with significantly impaired Th2 cell responses and
markedly enhanced Foxp3+ Treg cell induction (Figures 3A–3C
and S2F). Reconstitution of the mast-cell-deficient mice with
WT bone-marrow-derived mast cells (BMMCs) restored Th2
cell responses while partially but significantly restoring IgE pro-
duction (Figures 3A and 3B). Mast-cell-reconstituted mice ex-
hibited impaired Treg cell generation (Figure 3C). Unlike their
mast-cell-sufficient counterparts, mast-cell-deficient mice sub-
jected to peanut sensitization were protected from anaphylaxis,
but anaphylaxis was restored by mast cell reconstitution (Fig-
ure 3D). In contrast to WT BMMC-reconstituted mice, mice
reconstituted with IL-4-deficient mast cells failed to develop
peanut-specific IgE, Th2 cells, or anaphylactic responses,
instead showing enhanced Treg cell induction (Figure 3). Mast
cell reconstitution of the small intestine of mast-cell-deficient
mice was confirmed by histologic examination (Figure S3).
Although KitW-sh mice exhibit complete mast cell deficiency
and are amenable to reconstitution by BMMCs, making them
an attractive model system in which to study mast cell biology,
they have an array of immunological defects including dysregu-
lation of granulocytes, introducing potential complications to the
interpretation of our results. In order to further evaluate mast cell
functions in the peanut allergy model, we took advantage of the
Kit-independent Mcpt5cre transgene system to genetically target
mast cells. A two-pronged approach was applied that used
Mcpt5 promoter-driven Cre expression either to mediate mast
cell deletion via induction of iDTR followed by treatment with
diphtheria toxin (Il4ratm3.1Tch Mcpt5cre iDTR) or to drive mast-
cell-specific excision of the Sykb gene (Il4ratm3.1Tch Mcpt5cre
Sykfl/fl). We reasoned that removing Syk, the proximal kinase in
FcεRI signaling, would paralyze IgE-mediated mast cell activa-
tion, allowing us to isolate the role of IgE-mediatedmast cell acti-
vation within this model (Figures S4 and S5).(D) Flow cytometric analysis of Foxp3+ cells in the CD3ε+CD4+ MLN cells
exhibiting proliferative responses to PN after in vitro restimulation with
100 mg/ml PN for 5 days (n = 4–9).
Data are from one of two experiments and are represented as mean ± SEM.
Figure 3. Mast Cells Are Required for Sensi-
tization to Food Allergens
(A) PN-specific IgE levels in sera as determined by
ELISA. IL-4ra F709 mutant (Il4ratm3.1Tch) and mast-
cell-deficient Il4ratm3.1TchKitW-sh mice (n = 6–8)
were sensitized by enteral gavage with 23 mg PN
once a week for 8 weeks. Mast cells were
reconstituted in additional Il4ratm3.1TchKitW-sh mice
by i.p. injection of WT or IL-4-deficient (Il4tm1Cgn)
BMMCs (5 3 106) at 4 and 8 weeks prior to
sensitization. Kit variants are abbreviated as + for
WT and  for KitW-sh.
(B) IL-4+CD4+ T cells in the MLN.
(C) Foxp3+ Treg cell frequencies in CD3ε+CD4+
MLN cells exhibiting proliferative responses to PN.
(D) Temperature curves after acute enteral chal-
lenge with PN (450 mg) after sensitization of IL-4ra
F709 mutant (Il4ratm3.1Tch).
p < 0.001 by RM two-way ANOVA Kit+/+ versus
KitW-sh, KitW-sh versus KitW-sh + BMMCs, and
KitW-sh + BMMCs versus KitW-sh + Il4tm1Cgn
BMMCs. Data shown are from one of two experi-
ments and are depicted as mean ±SEM.
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mast cell ablation or mast cell paralysis behaved similarly, exhib-
iting both a restoration of oral tolerance and reduction in the pea-
nut allergic phenotype. Specific IgE and Th2 cell responses were
reduced in thesemice relative to controls (Figures 4A and 4B). As
we had observed with the KitW-sh model, removal of mast cells
was sufficient to restore Treg cell generation to near wild-type
levels even in the face of the proallergic IL-4ra F709 mutation
(Figure 4C). Anaphylaxis was undetectable in peanut-sensitized
Il4ratm3.1Tch Mcpt5cre iDTRmice that received DT treatment prior
to sensitization and was similarly absent in peanut-sensitized
Il4ratm3.1Tch Mcpt5cre Sykfl/fl mice (Figure 4D). Strikingly, deletion
of Syk solely from mast cells was sufficient to restore Treg cell
induction, identifying IgE crosslinking of FcεRI on mast cells as
the key signal tipping the balance between allergy and tolerance
after food allergen exposure in an environment genetically
permissive for the induction of food allergy.
In summary, these observations demonstrate that allergic
sensitization (Th2 cell responses and IgE production) are
reduced and Treg cell responses enhanced in two independent
strains of mice harboring the activating IL-4ramutation but lack-
ing mast cells and in mice in which FcεRI signaling is impaired
specifically in mast cells. Repletion of themast cell compartment
by wild-type but not IL-4-deficient BMMC transfer restores the
food-allergy-prone phenotype of the IL-4ra mutant mice, con-
firming a direct role for mast cells and IL-4 produced by them
in driving allergic sensitization and suppressing tolerance.
Syk Blockade Prevents Allergic Sensitization in Naive
Mice and Facilitates Induction of Tolerance in
Food-Allergic Animals
As the key kinase in FcεRI receptor signaling, Syk represents an
attractive target for pharmacologic inhibition in the treatment ofImmunity 41, 141–allergic disease. We have recently char-
acterized a new highly specific, potent,
orally bioavailable Syk inhibitor, SYKi,and applied this to probe the consequences of FcεRI blockade
in the peanut model (Moy et al., 2013). SYKi displayed a dose-
dependent inhibition of passive IgE-mediated anaphylaxis and
completely abrogated the lethal anaphylactic reaction to acute
food allergen challenge in sensitized IL-4ra mutant mice (Fig-
ure S6). We anticipated that inhibition of Syk would block sensi-
tization to food allergens, much the way that sensitization was
blocked in mice with targeted genetic deletion of Syk in mast
cells. This proved to be the case. Peanut-specific IgE responses
were very low or undetectable in mice treated with SYKi during
sensitization, and T cell responses correspondingly shifted
from Th2 cell biased to Treg cell dominated (Figures 5A–5C).
Peanut-specific IgG1 responses remained largely intact in
SYKi-treated mice, indicating that the absence of IgE did not
result from a global suppression of B cell function. However,
we cannot rule out effects on Syk-mediated B cell receptor
signaling by this compound (Figure 5D). Treatment with SYKi
during sensitization was sufficient to prevent the development
of anaphylactic food allergy to peanut, limiting temperature
loss and preventing MMCP-1 release (Figures 5E and 5F). To
ensure complete clearance of SYKi, peanut challenge was per-
formed after a 10-day ‘‘wash-out’’ period.
In order to test whether Syk inhibition, like anti-IgE treatment,
might facilitate tolerance induction in peanut-allergic animals,
mice were sensitized to peanut and then separated into groups
that received (1) no further treatment, (2) high-dose peanut
desensitization, or (3) high-dose daily peanut under cover of
SYKi. Mice were evaluated 10 days after the discontinuation of
therapy. Mice subjected to peanut sensitization and those with
peanut-only desensitization therapy developed normal anaphy-
lactic reactions; the SYKi plus peanut group tolerated the chal-
lenge and displayed no symptoms of anaphylaxis (Figures 6A
and S7). MMCP-1 release was reduced by approximately 2151, July 17, 2014 ª2014 Elsevier Inc. 145
Figure 4. Deletion of Syk in Mast Cells Pre-
vents Peanut Sensitization
(A) PN-specific IgE levels in sera. Mast-cell-
directed induction of the diphtheria toxin receptor
(DTR) or inactivation of Syk tyrosine kinase on the
IL-4ra F709 (Il4ratm3.1Tch) background were ach-
ieved by Mctp5cre-driven gene expression. Mice
expressing iDTR on mast cells (Il4ratm3.1Tch
Mcpt5cre iDTR) or with mast-cell-targeted Syk
deletion (Il4ratm3.1Tch Mcpt5cre Sykfl/fl) (n = 6–11)
were sensitized once a week for 4 weeks with
23 mg PN i.g. Mast cells were depleted from
Mcpt5cre iDTR mice by i.p. injection of diphtheria
toxin over 3 days (100 ng, 500 ng, 500 ng) 1 week
prior to initiating PN sensitization (indicated as
iDTR DT ‘‘+’’).
(B) ELISA analysis of PN-specific IL-4 secretion in
splenocyte cultures.
(C) Foxp3+ Treg cell frequencies among PN-re-
sponding CD3ε+CD4+ T cells from the MLN.
(D) Temperaturecurves fromPN-treated Il4ratm3.1Tch
mice after enteral challenge with high-dose PN
(450 mg).
p < 0.001 by RM two-way ANOVAMcpt5cre versus
Mcpt5cre iDTR and Mcpt5cre versus Mcpt5cre
Sykfl/fl. Data shown are a pool of three indepen-
dent experiments, represented as mean ± SEM.
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absent in the tolerized mice, and specific Treg cell frequencies
increased (Figures 6C and 6D). Peanut-specific IgE was reduced
in mice receiving SYKi plus peanut compared with mice
receiving peanut-only desensitization (Figure 6E). Our data
demonstrate that the addition of SYKi to peanut desensitization
markedly altered several critical aspects of the food allergen
immune response in a manner consistent with tolerance induc-
tion (Figure S7).
Tolerance to foods is maintained in part by Treg cells and
Treg cell deficiency is associated with severe food allergy (Ben-
nett et al., 2001; Chatila et al., 2000; Wildin et al., 2001). Our
analysis of Foxp3+ T cell frequencies in both the peanut and
OVA food allergy models suggested that the mechanism under-
lying peanut desensitization in the setting of IgE:FcεRI signaling
blockade was the induction of functional Treg cell, capable of
suppressing effector T cell responses. This potential mecha-
nism was directly evaluated by preparing Foxp3-eGFP+ Treg
cells from mice that had been sensitized to peanut in the pres-
ence or absence of SYKi and transferring these cells into naive
Il4ratm3.1Tch recipients, which were in turn sensitized to peanut
(Figure 7A). Treg cells from peanut+SYKi-treated donors almost
completely ablated specific IgE responses in peanut-fed recip-
ients (Figure 7B). T cell responses in the same mice exhibited
significant shifts from Th2 cell to Treg cell biased (Figures 7C,
7D, S2G, and S2H). Only mice given Treg cells from
peanut+SYKi-treated mice exhibited reductions in anaphylaxis
and MMCP-1 release upon peanut challenge (Figures 7E and
7F). Recipients of Treg cells from mice exposed to peanut in
the absence of SYKi had much more modest (and only signifi-146 Immunity 41, 141–151, July 17, 2014 ª2014 Elsevier Inc.cant in the case of IgE) trends relative to mice that did not
receive Treg cells.
Taken together, these results show that pharmacologic
blockade of FcεRI signaling via a Syk inhibitor prevents food
allergen sensitization and promotes tolerance induction in
food-allergy-prone IL-4ra mutant mice. The Treg-cell-skewing
effect of Syk inhibition can be exploited to restore tolerance in
mice with established allergy. Our observations of food allergy
suppression in recipients of Treg cells confirm the role of func-
tional peanut-specific Foxp3+ Treg cells in oral tolerance. SYKi
has no activity in T cells and in the context of our corroborating
data using mice with lineage-specific Syk deletion in mast cells,
mast cell deficiency models, and anti-IgE treatment, we attribute
the block in functional Treg cell induction to FcεRI signaling
blockade rather than any T-cell-intrinsic effect.
DISCUSSION
Mast cells reside at the interfaces between the body and the
environment, stationing them as sentinels for the immune sys-
tem. IgE antibodies arm these innate immune cells for specific
antigen recognition. In the setting of food allergy, our findings
suggest a triple function for these first-line defenders: (1) as
effectors of anaphylactic reactions in allergen-exposed subjects,
(2) as amplifiers of nascent Th2 cell and IgE responses during
recurring sensitizing ingestions of food allergen, and (3) as sup-
pressors of functional Foxp3+ Treg cell induction. Our report
shows that mast cells and IgE:FcεRI signaling are required for
the induction of adaptive Th2 cell immunity to ingested allergens
and that they counter Treg cell expansion; in the absence ofmast
Figure 5. Targeted Pharmacologic Inhibition of Syk Blocks Food
Allergen Sensitization
(A) PN-specific IgE levels in sera as measured by ELISA. IL-4ra F709
(Il4ratm3.1Tch) mutant mice (n = 12–15) were sensitized once a week by enteral
gavage with PN (23 mg) for 4 weeks. Mice were also gavaged with the Syk
inhibitor SYKi (30 mg/kg) or vehicle (10% Tween-80 [pH 8.0], 5 ml/kg) 15 min
prior to PN, 10 hr post-PN, and 24 hr post-PN. Abbreviations: PN, PN plus
vehicle during sensitization; PN+SYKi, PN plus SYKi during sensitization.
(B) Flow cytometric analysis of IL-4 production by expanded CD4+ MLN cells
exhibiting proliferative responses to PN in vitro (n = 5).
(C) Frequency of Foxp3+ cells among CD3ε+CD4+ T cells proliferating to PN
in vitro (n = 12–15).
(D) Serum levels of PN-specific IgG1 after sensitization, as determined by
ELISA.
(E) Degranulatory release of MMCP-1 into serum after sensitization and
challenge with PN (n = 10–11). There was a 10-day interval between the final
SYKi treatment and the PN challenge.
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minimal Th2 cell and IgE responses but had robust Treg cell in-
duction. This work was carried out with an innovative array of
research tools including the novel IL-4ramutant model of peanut
allergy, in which enteral ingestion alone leads to anaphylactic
food sensitivity, and a potent selective Syk inhibitor to modulate
IgE:FcεRI signaling. The observation that inhibition of IgE
signaling with anti-IgE antibody or Syk inhibition in the setting
of pre-existing allergy leads to reversal of IgE and Th2 cell re-
sponses along with Treg cell expansion is completely new and
quite striking. This result reveals significant plasticity in food
allergy responses and points to Syk as an attractive therapeutic
target in food allergy.
Food allergy has been notoriously difficult to model in mice.
Even with the use of adjuvants and parenteral priming, which
bypass normal immune-sensitization mechanisms, responses
to food challenge are weak. Challenged animals do not exhibit
anaphylaxis, a cardinal symptom of food allergy in patients.
The IL-4ra mutant mice have provided a powerful genetic tool
to address the pathogenesis of food allergy in amore physiologic
setting. We believe the inherent predisposition to allergy, based
on enhanced IL-4ra responses, in thesemice reflects a cytokine-
signaling imbalance that might be at work in atopic humans. We
have previously reported that an IL-4ra polymorphism affecting
signaling strength is linked to asthma (Hershey et al., 1997). In
studies designed to identify loci linked with IgE production, the
chromosome 5q31 cytokine cluster, which contains the gene
encoding IL-4, is consistently identified (Marsh et al., 1994;
Meyers et al., 1994; Xu et al., 1995), and one preliminary study
reported a significant association between an IL4Ra polymor-
phism and food allergen-specific IgE levels (Brown et al.,
2012). We believe that deletion of the ITIM in the IL-4Ra of the
micewe have studied and the resultant disinhibition of the recep-
tor are paradigmatic of the situation in atopic humans in whom
nascent allergic sensitization also appears to be affected by an
altered IL-4 signaling axis.
We and others have previously demonstrated that IgE anti-
bodies exert important effects on mast cells above and beyond
the induction of degranulation and immediate hypersensitivity.
Even in the absence of antigen, IgE regulates mast cell homeo-
stasis in culture and in vivo and modulates mast cell cytokine
production (Asai et al., 2001; Bryce et al., 2004; Kalesnikoff
et al., 2001; Kawakami and Kitaura, 2005; Mathias et al., 2009).
Similar effects on mast cell cytokine production are observed
in systems involving antigen-driven IgE signaling as well (Galli
et al., 2005; Nakae et al., 2007a). The effects of IgE-mediated
mast cell signaling in modulating Th2 cell and Treg cell re-
sponses in the peanut allergy system in this report are corrobo-
rated by four independent lines of investigation: the study of
IgE-deficient mice, anti-IgE treatment, Mcpt5cre Sykfl/fl mice,
and SYKi treatment. Each of these experimental models demon-
strated impairment of Th2 cell and IgE responses along with(F) Temperature curves after acute challenge with PN (450 mg) in PN+vehicle-,
PN+SYKi-, or saline-treated mice (n = 5).
p < 0.001 by RM two-way ANOVA PN versus PN+SYKi. Data in (B) and (F) are
representative of two experiments each, whereas the data in (A), (C), (D), and
(E) have been pooled from three independent experiments. Data are shown as
points for individual mice with mean ± SEM.
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Figure 6. Pharmacological Inhibition of Syk Activity Enhances Food
Allergen Desensitization
(A) Temperature curves after acute challenge with PN in PN-sensitized (PN),
PN+SYKi-desensitized (PN, PN+SYKi), and mock-desensitized (PN, PN) mice
(n = 5). PN-sensitized IL-4ra F709 (Il4ratm3.1Tch) mutant mice were subjected to
3 weeks of daily oral desensitization therapy with PN (225 mg) (PN, PN) or PN
paired with SYKi (30mg/kg, p.o., b.i.d.) (PN, PN+SYKi). The final challenge was
performed in the absence of SYKi, 10 days after the final SYKi dose. PN-
sensitized mice that received no therapy after sensitization are shown for
comparison (PN). p = 0.0016 by RM two-way ANOVA for PN versus PN,
PN+SYKi or PN, PN versus PN, PN+SYKi.
(B) MMCP-1 levels in serum postchallenge (n = 4–5).
(C) IL-4 secretion by splenocyte cultures in response to PN stimulation
(n = 9–10).
(D) PN-specific Treg cell frequencies in dividing MLN CD3ε+CD4+ cells
(n = 5–6).
(E) Serum levels of peanut-specific IgE (n = 9–10).
Data shown are representative of two independent experiments (A, B, and D)
or have been pooled from two experiments (C and E) and are represented as
mean ± SEM.
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for a Th2 cell adjuvant effect of IgE signaling in emerging food
allergy responses. These results have potential implications for
the design of strategies to achieve safe and effective oral desen-
sitization in patients with peanut allergy. Although anti-IgE treat-
ment during food desensitization has recently been applied
in clinical trials, the immunomodulatory effects of such IgE
blockade are not yet known.
The role of mast cells in murine disease models is challenging
to assess given the limitations of each of the various mast cell
deficiency models (Rodewald and Feyerabend, 2012). The fully
consistent results we independently obtained with both Kit-
dependent and -independent models of deficiency (KitW-sh and
Mcpt5cre iDTR, respectively) provide strong converging support
for a critical mast cell contribution to Th2 cell induction and Treg
cell suppression. Whereas Mcpt5cre iDTR mice have previously
been reported to have an intact mucosal mast cell compartment
(based on baseline histologic analyses of the stomach), we have
found that IL-4-driven and allergen-induced mucosal mast cell
expansion in the jejunum is in fact suppressed in these animals,
and it has been reported that MMCP-5 expression is not
restricted to submucosal mast cells under Th2 cell conditions
(Friend et al., 1996; Xing et al., 2011). DT-treated animals ex-
hibited both impaired mast cell expansion and the same block
in Th2 cell and IgE responses observed in IgE-deficient and
KitW-sh mutants.
Although mast cells are not MHCII+ and may not function as
antigen-presenting cells in this food allergy model system, we
observed that they accumulate in the draining lymph nodes of
sensitized animals, placing them proximal to T cell priming
events. By immunofluorescent microscopy, both Treg cells
and mast cells are present in the jejunal lamina propria and
Peyer’s patches (data not shown). Mast cells are known to pro-
duce significant amounts of the critical Th2-cell-inducing cyto-
kine IL-4, which has the capacity both to subvert Treg cell
generation, by destabilizing Foxp3 expression, and to simulta-
neously activate the Th2 and Th9 cell pathways via STAT6 sig-
nals (Dardalhon et al., 2008; Wang et al., 2010). We observe
that when mast cells are cultured with naive T cells under
Treg-cell-inducing conditions, FcεRI crosslinking inhibits TGF-
b-driven expansion of Foxp3+ T cells. Furthermore, we find
that Il4 and Il13 transcripts are very rapidly induced (within
1 hr) in the small intestine after allergen exposure and that these
transcripts are Syk and IgE dependent, strongly implicating
mast cells as cellular sources of IL-4 and IL-13 early after
food ingestion. Our results from WT versus IL-4-deficient
mast cell reconstitution of mice lacking mast cells demonstrate
an essential role for mast-cell-derived IL-4 in promoting sensi-
tization to ingested allergen.
Our findings that (1) peanut-specific Treg cell frequencies are
higher in IgE-deficient, anti-IgE-treated, mast cell-deficient,
mast cell Syk-deficient, and SYKi-treated mice and that (2)
Treg cells from peanut-fed SYKi-treated mice functionally sup-
press the induction of peanut allergy in naive recipients identify
a central mechanism whereby IgE antibodies and mast cells
enhance emerging allergic sensitization: they suppress effective
Treg cell responses. We and others have previously demon-
strated that inherited Foxp3 deficiency leads to severe intrac-
table food allergy and that patients with Foxp3 mutations lack
Figure 7. Treg Cells Induced while Mast Cells Are Paralyzed Effec-
tively Control Food Allergen Sensitization
(A) Experimental schematic. IL-4ra F709 mutant Thy1.1-congenic Foxp3-
eGFP (Il4ratm3.1Tch Foxp3tm2Tch Thy1a) donor mice (n = 5) were sensitized to
peanut with or without SYKi for 4 weeks, at which point their CD4+Foxp3-
eGFP+ Treg cells (TR) were purified and transferred (43 10
5/mouse) into naive
IL-4ra F709 (Il4ratm3.1Tch) recipients (for PN and PN+SYKi TR groups). Mice that
did not receive Treg cells are included as positive controls for peanut sensi-
tization. All recipient mice were sensitized with 23 mg PN once a week for
4 weeks and challenged with 450 mg PN by gavage (n = 5).
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Wildin et al., 2001).
Syk inhibition offers an attractive pharmacologic approach
for blocking IgE-induced FcεRI signaling. Previously available
small-molecule Syk inhibitors have had significant off-target
effects, however, especially on the closely related kinase
ZAP70 in T cells. SYKi, used in this study, has >25-fold enhanced
specificity for fully phosphorylated Syk versus ZAP70 (Moy et al.,
2013). Although Syk is also the proximal signaling kinase for the
B cell receptor (BCR), we believe that its major effects on allergic
responses to peanut in our study resulted from its FcεRI inhibi-
tion. In support of this conclusion is our finding that the pheno-
type of peanut-fed mice in which Syk is specifically inactivated
in mast cells, but not B cells, exactly mirrors that of the SYKi-
treated animals. BCR activation is normal in the mice with
mast-cell-targeted Syk gene deletion yet they exhibited the
same impairment in Th2 cell and IgE induction and enhanced
Treg cell responses to SYKi-treated mice, consistent with an
FcεRI-driven effect.
In summary, our study provides clear evidence that IgE-medi-
ated mast cell activation serves not only to elicit immediate hy-
persensitivity reactions but also to amplify evolving allergic
sensitization to ingested proteins. We speculate that manipula-
tions of the IgE axis might some day provide clinical benefit.
EXPERIMENTAL PROCEDURES
Mice
Detailed mouse information can be found in the Supplemental Experimental
Procedures. All mice were bred and maintained under specific-pathogen-
free conditions at Boston Children’s Hospital. All animal experiments were
conducted under procedures approved by the Boston Children’s Hospital
Institutional Animal Care and Use Committee.
Allergic Sensitization and Anaphylaxis
Mice were sensitized by enteral gavage with ball-tipped 18 g feeding needles.
Peanut butter (Skippy, Hormel Foods) was gavaged in 250 ml 0.1 M sodium
bicarbonate (pH 8.0). Mast cells were depleted by i.p. injection of diphtheria
toxin (List Biological Laboratories) in saline over 3 days: 100 ng day 1,
500 ng day 2, and 500 ng day 3. SYKi was prepared as previously described
(Moy et al., 2013) and solubilized in pH 8.0 aqueous isosmotic Tween-80
(10% w/v, Sigma). SYKi (30 mg/kg) and vehicle control were delivered by
gavage in 5 ml/kg. Anti-IgE (clone R35-92, BD) was injected i.p. in tripling
doses every hour starting at 50 ng, integrating to a total of 25 mg the first
day. Over the next 3 days, 25 mg anti-IgE was injected once a day i.p., giving
a total of 100 mg anti-IgE per mouse. Core body temperature measurements
taken to monitor anaphylaxis were recorded by subdermally implanted tran-
sponders (IPTT-300) and a DAS-6001 console (Bio Medic Data Systems)
linked to a netbook. For sensitization protocols and further information, see
Supplemental Experimental Procedures (Figure S1).(B) PN-specific IgE production in recipient mice.
(C) Flow cytometric analysis of IL-4 in CD4+ T cells from the MLN.
(D) Foxp3+ Treg cell frequencies in the MLN of recipient mice as assessed by
flow cytometric analysis of CD4+CD3ε+ cells taken directly ex vivo.
Data in (C) and (D) exclude Thy1.1+ donor cells from the analyses.
(E) SerumMMCP-1 release after acute enteral challenge of recipient mice with
PN (450 mg).
(F) Core temperature loss after PN challenge in recipient mice (p < 0.001 by RM
two-way ANOVA No TR versus PN+SYKi TR and PN+SYKi TR versus PN TR).
The skull-and-crossbones symbol indicates a death from anaphylaxis in the
PN TR group.
Data are from a single experiment, and are shown as mean ± SEM.
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Bone-marrow-derived mast cells (BMMCs) were cultured as previously
described (Burton et al., 2013). BMMCs were used for reconstitution experi-
ments after 3–6 weeks of culture. Splenocytes were cultured in RPMI-1640
supplemented as previously described (Burton et al., 2013) and stimulated
for antigen-specific recall with 100 mg/ml peanut extract. Endogenous
allergen-specific T cells were identified by allergen-induced ex vivo prolifera-
tion, along the lines of assays developed for assessing human tetanus
toxoid recall (Narendran et al., 2002). MLN cells (5 3 106) were labeled with
Violet CellTrace (Life Technologies) and cultured with or without allergen
(100 mg/ml peanut extract) for 5 days. Cells undergoing proliferation (dye dilu-
tion) were considered allergen specific, a conclusion supported by a lack of
proliferation in the absence of allergen or in allergen-stimulated cells from
unsensitized mice. We note that this approach does not provide the absolute
number of Treg cells residing in the MLN but nevertheless gives a robust
readout of the relative efficiency with which Treg cells are induced among
experimental groups.
Mast Cell Reconstitution
Weanling Il4ratm3.1Tch KitW-sh mice were injected i.p. with 53 106 BMMCs and
a second injection of BMMCs was performed 4 weeks later. Allergic sensitiza-
tion was started 8 weeks after the initial transfer, at which point mast cell
reconstitution of intestinal compartments has been shown to be evident (Grim-
baldeston et al., 2005). Reconstitution was performed with matched cultures
of WT C57BL/6J and IL-4-deficient B6.129P2-Il4tm1Cgn/J (stock number
002253) mast cells prepared from age-matched female mice purchased
from Jackson Laboratories.
Histology
Sections of the jejunum were taken approximately 10 cm from the pyloric
sphincter and fixed overnight in 10% formalin (Sigma). Samples were stored
in 70%ethanol prior to processing and toluidine blue staining by the Beth Israel
Deaconess Medical Center Histology Core. Chloroacetate esterase staining,
which stains mast cells with a characteristic red color, was performed as pre-
viously described (Burton et al., 2013; Friend et al., 1998). Samples were ran-
domized and coded prior to histological processing, with scoring and staining
being performed by an investigator unaware of the sample identities.
Statistics and Data Analysis
Data were graphed and analyzed with GraphPad Prism 5.0. Anaphylaxis tem-
perature curves were analyzed by repeated-measures two-way ANOVA for
overall distinction between treatment groups. Unpaired t tests were used to
compute two-tailed p values for comparisons between two groups. For three
or more groups, ANOVA was used, with individual p values coming from
Bonferroni posttests. p values are abbreviated as *p < 0.05, **p < 0.01,
***p < 0.001, ****p < 0.0001. Because peanut-specific IgE and MMCP-1 levels
varied by a few orders of magnitude, these data are presented on graphs with
logarithmic y axes and were log-transformed prior to statistical analysis.
Samples in which specific immunoglobulins or MMCP-1 were undetectable
were assigned a nominal value corresponding to the limit of detection in the
assay (0.3125 units/ml for peanut-specific IgE). Data are presented as
mean ± SEM, with points representing individual mice where presented.
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